• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,269
3,566
3,454
2,870
2,805

COUNTRY

2,401
896
277
267
231

CATEGORIES

  • 947
  • 175
    • 43
    • 256
    • 50
  • 115
  • 295
    • 48
  • 505
  • 258
  • 241
  • 59
  • 59
  • 856
  • 1,504
  • 822
  • 20
  • 496
  • 1,424
  • 2,399
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 269
  • 32
  • 2,637
SHOW ALL…

PRICE

2,358
7,647
16,473
29,231

PUBLISHED

2,033
4,510
11,703
29,231

PRODUCT TYPE

26,270
1,085
1,038
524
163
58
24
21
21
16
6
4
1

Pharmaceuticals

(29,231 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Left Ventricular Hypertrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Left Ventricular Hypertrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Left Ventricular Hypertrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Left Ventricular Hypertrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Gastric Motility Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Gastric Motility Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Gastric Motility Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Gastric Motility Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Cataract. A key...

February 2015
FROM
Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Migraine. A key...

February 2015
FROM
Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Hyperlipidemia....

February 2015
FROM
Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Von...

February 2015
FROM
Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Uterine...

February 2015
FROM
Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Ocular...

February 2015
FROM
Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Mixed...

February 2015
FROM
Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Crohn's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Crohn's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Crohn's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Crohn's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Crohn's Disease....

February 2015
FROM
Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tonsillitis....

February 2015
FROM
Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pharyngitis....

February 2015
FROM
Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Graves Diseases....

February 2015
FROM
T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the T-Cell Leukemia....

February 2015
FROM
Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Smallpox. A key...

February 2015
FROM
Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dyslipidemia....

February 2015
FROM
Adrenal Insufficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Adrenal Insufficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Adrenal Insufficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Adrenal Insufficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Adrenal...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S